Known Risks
Sophisticated audiences respect founders who name their risks. Pretending they don’t exist signals naivete. Addressing them directly builds trust.
CMS Could Standardize File Formats
If CMS mandates a single file format for hospital pricing, it would reduce the parsing complexity that is one dimension of ClearPrice’s moat.
Mitigation: This would actually be good for the market and accelerate ClearPrice’s coverage expansion. The moat is increasingly in fused intelligence (rates + Medicare + plans + quality) and data quality — not solely in parsing. And government standardization takes years.
CMS Could Build a Government Consumer Tool
CMS has the data. They could theoretically build a consumer-facing price comparison tool.
Mitigation: Government-built consumer tools have a consistent track record of underperformance relative to market alternatives. ClearPrice would continue serving B2B segments regardless.
Turquoise Health Could Move Downstream
Turquoise has $60M+ in funding and could decide to build consumer or advisor products.
Mitigation: Enterprise data companies rarely execute well on consumer product design — different customer, different sales motion, different product instinct. ClearPrice’s consumer-first architecture represents fundamentally different product decisions.
Major Payer Could Build Internally
UnitedHealth Group or Elevance could build an internal transparency tool with their own data.
Mitigation: Payers have conflicting incentives around full transparency — genuine cross-payer comparison can highlight unfavorable rate differentials. An independent third party has credibility that a payer-owned tool does not.
Solo Founder Dependency
The entire platform — pipeline, products, operations — was built by one person. Bus factor = 1.
Mitigation: Platform designed for operational independence: automated weekly pipeline, CI/CD deployment, test suites, structured documentation. Team-building is the explicit next phase, not an afterthought.
Pre-Revenue
No revenue yet. Products are live and operational, but nobody has written a check.
Mitigation: Product is built, data is operational, go-to-market plan is defined with specific segments and targets. Revenue timeline: first broker pilot conversations Q2 2026. The product risk is behind us — the market risk is ahead.